BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 17342190)

  • 1. X-linked adrenoleukodystrophy.
    Moser HW; Mahmood A; Raymond GV
    Nat Clin Pract Neurol; 2007 Mar; 3(3):140-51. PubMed ID: 17342190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of X-linked adrenoleukodystrophy.
    Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
    Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients.
    Moser HW; Loes DJ; Melhem ER; Raymond GV; Bezman L; Cox CS; Lu SE
    Neuropediatrics; 2000 Oct; 31(5):227-39. PubMed ID: 11204280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenoleukodystrophy: new approaches to a neurodegenerative disease.
    Moser HW; Raymond GV; Dubey P
    JAMA; 2005 Dec; 294(24):3131-4. PubMed ID: 16380594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endocrine disease in adrenoleukodystrophy].
    Girard S; Bruckert E; Turpin G
    Ann Med Interne (Paris); 2001 Feb; 152(1):15-26. PubMed ID: 11240421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes.
    Mahmood A; Dubey P; Moser HW; Moser A
    Pediatr Transplant; 2005 Dec; 9 Suppl 7():55-62. PubMed ID: 16305618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic aspects of X-linked adrenoleukodystrophy.
    Gärtner J; Braun A; Holzinger A; Roerig P; Lenard HG; Roscher AA
    Neuropediatrics; 1998 Feb; 29(1):3-13. PubMed ID: 9553942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenoleukodystrophy.
    Moser HW; Bergin A; Naidu S; Ladenson PW
    Endocrinol Metab Clin North Am; 1991 Jun; 20(2):297-318. PubMed ID: 1879401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
    N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy].
    Stradomska TJ; Tylki-Szymańska A
    Pediatr Pol; 1996 Mar; 71(3):197-201. PubMed ID: 8966090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for carrier and prenatal diagnosis of X-linked adrenoleukodystrophy].
    Wang AH; Bao XH; Xiong H; Pan H; Wu Y; Zhang YH; Shi CY; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):345-9. PubMed ID: 15924749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy.
    Moser HW
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):740-5. PubMed ID: 7666063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.
    Moser HW; Moser AE; Singh I; O'Neill BP
    Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [X-linked adrenoleukodystrophy (X-ALD)].
    Fenchel M; Korn A; Nägele T; Ernemann U; Horger M
    Rofo; 2011 Dec; 183(12):1093-6. PubMed ID: 22220308
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenoleukodystrophy.
    Cappa M; Bizzarri C; Vollono C; Petroni A; Banni S
    Endocr Dev; 2011; 20():149-160. PubMed ID: 21164268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of X-linked adrenoleukodystrophy.
    Moser HW
    NeuroRx; 2006 Apr; 3(2):246-53. PubMed ID: 16554262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A man with progressive spastic paraparesis].
    Sanaker PS; Lindland S; Rekeland F; Bindoff LA
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3085-7. PubMed ID: 18098376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.